Drug Trials Snapshot: ALYFTREK

by Pill Pals Customer Service | Jun 25, 2025 | News

HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, and whether there were differences among sex, race, age, and ethnic groups. The “MORE INFO” bar...

Update HCP Drug Interactions

by Pill Pals Customer Service | Jun 25, 2025 | News

abiraterone 2D6 moderate inhibitor acyclovir 1A2 weak inhibitor adefovir1 OAT1 substrate alfentanil 3A4 sensitive substrate allopurinol 1A2 weak inhibitor alosetron ...

Warning: infection of genital area with SGLT2 inhibitors for diabetes

by Pill Pals Customer Service | Jun 25, 2025 | News

[8-29-2018] The U.S. Food and Drug Administration (FDA) is warning that cases of a rare but serious infection of the genitals and area around the genitals have been reported with the class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2)...

Early Lyme Disease as Manifested by Erythema Migrans

by Pill Pals Customer Service | Jun 25, 2025 | News

Docket Number: FDA-2022-D-2315 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled “Early Lyme Disease as Manifested by...

FDA Investigating Deaths Due to Acute Liver Failure in Non-ambulatory

by Pill Pals Customer Service | Jun 24, 2025 | News

FDA Safety Communication – June 24, 2025Summary of the IssueSince approval, the Food and Drug Administration (FDA) has received two reports of fatal acute liver failure following treatment of non-ambulatory pediatric male patients with Duchenne Muscular Dystrophy...

FIBRYGA

by Pill Pals Customer Service | Jun 24, 2025 | News

STN# 125612Proper Name: Fibrinogen (Human)Tradename: FIBRYGAManufacturer: OCTAPHARMA Pharmazeutika Produktionsges.m.b.H.Indication:FIBRYGA is a human fibrinogen concentrate indicated for:fibrinogen supplementation in bleeding patients with acquired fibrinogen...